切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Free Fatty Acid Receptors - RET - PP2A/Nkd interaction - Urokinases

10 件产品

每页
清除全部
  1. AH 7614
    B7792 AH 7614
     1 Citation
    Target: Free Fatty Acid Receptors
    Summary: FFA4/GPR120拮抗剂
      ≥35.1 mg/mL
      insoluble in H2O
  2. IQ 1
    B7700 IQ 1
    Target: Stem Cell Differentiation|PP2A/Nkd interaction
    Summary: 维持胚胎干细胞(ESC)的多能性
      ≥37.5 mg/mL
      insoluble in H2O
  3. Amiloride HCl dihydrate
    B2268 Amiloride HCl dihydrate
    中文名: 盐酸阿米洛利二水合物
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Urokinases
    Summary: 有效上皮钠通道(ENaC)阻断剂
      ≥14.05 mg/mL
      insoluble in H2O
  4. GW9508
    A1709 GW9508
    Target: Free Fatty Acid Receptors
    Summary: FFA1/GPR40激动剂
      ≥16.05 mg/mL
      insoluble in H2O
  5. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    中文名: 乐伐替尼,仑伐替尼
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR抑制剂
      ≥21.35 mg/mL
      insoluble in H2O
  6. Regorafenib
    A8236 Regorafenib
     4 Citation
    中文名: 瑞戈非尼
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
      ≥25.04 mg/mL
      insoluble in H2O
  7. 4-Chlorophenylguanidine hydrochloride
    A4445 4-Chlorophenylguanidine hydrochloride
    Target: Urokinases
    Summary: 尿激酶(urokinase)抑制剂
      Soluble to 100 mM in H2O
  8. TUG-770
    A3895 TUG-770
    Target: Free Fatty Acid Receptors
    Summary: FFA1/GPR40激动剂
      ≥11.85 mg/mL
      insoluble in H2O
  9. AST 487
    A3194 AST 487
     1 Citation
    Target: RET
    Summary: RET激酶抑制剂
      ≥26.5 mg/mL
      insoluble in H2O
  10. ENMD-2076
    A4130 ENMD-2076
    Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-Fms
    Summary: Aurora A/Flt3的选择性抑制剂
      ≥18.75 mg/mL
      insoluble in H2O

10 件产品

每页